Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1991-10-10
|
pubmed:abstractText |
Hypothyroidism posttreatment of diffuse toxic goiter (DTG) might depend on both treatment of inherent disease factors. 147 patients afflicted with DTG, with at least 3 years under treatment, were studied to identify these factors. Clinical evaluation was performed and TSH and T4T were measured (RIA). 49% had hypothyroidism, 17% of this percentage having been diagnosed during the study. We found these hypothyroidism protector factors: familiar background of thyroid disease, gap between doses of 131 1 greater than of 8 months and as favoring factor: surgical treatment.
|
pubmed:language |
spa
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0212-7199
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
575-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2103211-Combined Modality Therapy,
pubmed-meshheading:2103211-Graves Disease,
pubmed-meshheading:2103211-Humans,
pubmed-meshheading:2103211-Hypothyroidism,
pubmed-meshheading:2103211-Thyroid Function Tests,
pubmed-meshheading:2103211-Thyrotropin,
pubmed-meshheading:2103211-Thyroxine,
pubmed-meshheading:2103211-Time Factors
|
pubmed:year |
1990
|
pubmed:articleTitle |
[Posttreatment hypothyroidism in diffuse toxic goiter. A complication or evolution?].
|
pubmed:affiliation |
Instituto Superior de Ciencias Médicas, Hospital Docente Clínico Quirúrgico 12 de Octubre, Ciudad de La Habana, Cuba.
|
pubmed:publicationType |
Journal Article,
English Abstract
|